As the results showed, in patients with HNSCC tumors, high FADD and LAMP expression levels had lower survival rates, while high MAP1LC3B levels were associated with favorable prognosis. The gene discussed is MAP1LC3B; the disease is head and neck squamous cell carcinoma.